Summit Therapeutics Inc. Weighted Average Exercise Price Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement
Summit Therapeutics Inc. (SMMT) reported Weighted Average Exercise Price Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement of GBP 0.01 for the 9-month period ending 2019-10-31, per its 6-K filed 2019-12-17.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement · last filed 2019-12-17
- Summit Therapeutics Inc. weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement for the quarter ending 2019-04-30 was 0.01 GBP.
- Summit Therapeutics Inc. weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement for the quarter ending 2018-04-30 was 0.00 GBP.
| Period end | Weighted Average Exercise Price Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement 3 month | Weighted Average Exercise Price Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement 6 month | Weighted Average Exercise Price Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement 9 month | Weighted Average Exercise Price Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2019-10-31 | 0.01 GBP 6-K · filed 2019-12-17 | |||
| 2019-07-31 | 0.01 GBP 6-K · filed 2019-10-11 | |||
| 2019-04-30 | 0.01 GBP 6-K · filed 2019-06-12 | |||
| 2019-01-31 | 0.01 GBP 20-F · filed 2019-03-29 | |||
| 2018-10-31 | 0.01 GBP 6-K · filed 2019-12-17 | |||
| 2018-07-31 | 0.01 GBP 6-K · filed 2019-10-11 | |||
| 2018-04-30 | 0.00 GBP 6-K · filed 2019-06-12 | |||
| 2018-01-31 | 0.00 GBP 20-F · filed 2019-03-29 | |||
| 2017-10-31 | 0.00 GBP 6-K · filed 2018-12-11 | |||
| 2017-07-31 | 0.00 GBP 6-K · filed 2018-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |